-+ 0.00%
-+ 0.00%
-+ 0.00%

Castle Biosciences CEO Derek J. Maetzold disposes of 550 common shares worth $12,606‬‬

PUBT·07/16/2026 20:16:45
Listen to the news
Castle Biosciences CEO Derek J. Maetzold disposes of 550 common shares worth $12,606‬‬
  • Castle Biosciences CEO Derek J. Maetzold exercised stock options for 550 shares at USD 2.39 on July 14, 2026.
  • Maetzold sold 550 shares at a weighted-average USD 22.92, cutting his direct stake to 21,479 shares.
  • Trust-held positions also fell via sales at USD 22.92, including 1,357 shares from The Maetzold Descendants 2020 Trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-048461), on July 16, 2026, and is solely responsible for the information contained therein.